CICLOSPORIN

CICLOSPORIN (13999T)

ciclosporin 10 mg capsule, 60
13999T
Body System:
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 240 # of repeats: 3 DPMQ: $176.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral 10

CICLOSPORIN (5632K)

ciclosporin 10 mg capsule, 60
5632K
Body System:
Manner of administration:Oral
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 6643)

Indication: Management of transplant rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6660)

Indication: Severe atopic dermatitis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 15360)

Indication: Severe psoriasis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6631)

Indication: Nephrotic syndrome
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 6638)

Indication: Severe active rheumatoid arthritis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 120 # of repeats: 5 DPMQ: $74.40 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral 10

CICLOSPORIN (6232B)

ciclosporin 10 mg capsule, 60
6232B
Body System:
Manner of administration:Oral
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9764)

Indication: Management of transplant rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 9695)

Indication: Severe atopic dermatitis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 15361)

Indication: Severe psoriasis
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 9694)

Indication: Nephrotic syndrome
Treatment phase: Management (initiation, stabilisation and review of therapy)

Restriction (Streamlined authority code: 9742)

Indication: Severe active rheumatoid arthritis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 120 # of repeats: 5 DPMQ: $87.28 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral 10

CICLOSPORIN (8657P)

ciclosporin 10 mg capsule, 60
8657P
Body System:
Manner of administration:Oral
General Schedule
No restrictions
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 120 # of repeats: 3 DPMQ: $93.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Neoral 10